SWOG clinical trial number
SWOG-9207

Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer

Closed
Phase
Accrual
62%
Published
Abbreviated Title
Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer
Activated
01/01/1993
Closed
06/01/1995

Research committees

Lung Cancer

Publication Information Expand/Collapse

1997

Phase II trial of edatrexate plus carboplatin in metastatic non-small cell lung cancer: A Southwest Oncology Group study.

DR Gandara;MJ Edelman;JJ Crowley;RB Livingston Cancer Chemotherapy and Pharmacology 41:75-78

1996

Edatrexate and carboplatin in stage IV non-small cell lung cancer: Phase II trial of the Southwest Oncology Group (SWOG).

D Gandara;M Edelman;G Smith;J Crowley;R Livingston American Society of Clinical Oncology 15:397(#1202)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402

Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open